Tag: Ectosense
ResMed buys HST company
October 4, 2021HME News Staff
SAN DIEGO – ResMed has bought Ectosense, which makes the NightOwl home sleep test.
The NightOwl, approved by the U.S. Food and Drug Administration, is currently sold in the United States, Australia, New Zealand, India and parts of Europe. ResMed has distributed the NightOwl, under the brand ResMed onesleeptest, in Australia, New Zealand and India since 2020, and has been a minority investor in Ectosense since July 2020.
"Sleep labs and home tests each have critical roles to...
CPAP Therapy, Ectosense, Home Sleep Testing, NightOwl, Obstructive Sleep Apnea (OSA), ResMed
Sponsored Stories
From Intake to Billing — SOS Handles It All for HME/DME Providers
By Strategic Office SupportHow Advanced Diabetes Supply is Driving Value-Based Health Outcomes
By Advanced Diabetes SupplySOS Achieves Remarkable 400% Growth in 2023, Bolsters Team with Director Appointment
By Strategic Office Support